Calypso Medical Announces First Post-Operative Prostatectomy Patient Implanted In Clinical Study To Track Tissue Motion During Radiation Therapy
Calypso Medical Technologies, Inc. today announced the initiation of its latest clinical study, the PROBE clinical study (Prostatic Bed Experience with the Calypso 4D Localization System) to guide delivery of intensity modulated radiation therapy (IMRT) in prostate cancer patients following radical prostatectomy.
Applied Biosystems To Webcast Presentation At UBS Global Life Sciences Conference
Applied Biosystems Inc. (NYSE:ABI) announced today that it will webcast its joint presentation with Invitrogen Corporation at the UBS Global Life Sciences Conference on Tuesday, September 23, 2008.
California Healthcare Institute To Host Forum On Molecular Diagnostics Regulation And Reimbursement Keeping Pace With Technology
California Healthcare Institute (CHI) and national experts in the molecular and in vitro diagnostics (IVD) industry. Keeping Pace with Technology: Molecular Diagnostics Regulation and Reimbursement.
Applied Biosystems Launches Service Provider Program For Real-Time RNA Expression Analysis
Applied Biosystems Inc. today announced that it has established a global service provider program for RNA expression analysis.
Geron Announces Issuance Of U.S. Patent For Cardiomyocytes From Human Embryonic Stem Cells
Geron Corporation today announced the issuance of U.S. Patent No. 7,425,448, with broad claims to cardiomyocytes derived from human embryonic stem cells (hESCs).
IPS Announces Winners Of “What A Waste” Contest
Integrated Project Services (IPS),today announced the winners of the company’s “What a Waste” Contest. Sponsored by the IPS Sustainable Leadership Team, the contest was developed to collect ideas for practical conservation and sustainability, material and waste reduction, and recycling or alternate uses of spent resources.
The Genome Institute Of Singapore Acquires Applied Biosystems Genomic Analysis Systems For Cancer Research
Applied Biosystems announced today that GIS will add three new SOLiD™ Systems to its existing base of genomics analysis technologies.
Applied Biosystems Expands Sequencing-Based RNA Analysis Solutions Portfolio
Applied Biosystems Inc. (NYSE:ABI) today announced the development of a sequencing-based molecular tool for the genomic analysis of whole transcriptomes, the vast collection of RNAs transcribed from a genome
BioTime, Inc.’s Subsidiary, Embryome Sciences, Inc., Licenses Virus-Free iPS And Embryonic Stem Cell Differentiation Technology
Embryome Sciences, Inc., a wholly owned subsidiary of BioTime, Inc. (OTCBB:BTIM), announced today the license of a portfolio of patents and patent applications from Advanced Cell Technology, Inc. (“ACT”) relating to induced pluripotent stem cells (“iPS”) and embryonic stem cell differentiation technology
STEMCELL Technologies Introduces AggreWell™400 For Standardized Embryonic Stem Cell And Induced Pluripotent Stem Cell Research
STEMCELL Technologies, a leader in specialty cell culture media, cell separation products and ancillary reagents for stem cell research, today announced the release of the AggreWell™400 plates, a revolutionary tool for researchers using embryonic and induced pluripotent stem cells (ESC and iPSC)